Chronic Limb-Threatening Ischemia: Clinical Trials

8 trials for Chronic Limb-Threatening Ischemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 8

Follow Chronic Limb-Threatening Ischemia: new trials by email Literature Review of Chronic Limb-Threatening Ischemia trials Research Report on Chronic Limb-Threatening Ischemia

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study
StellarexTM 0.014" Over-The-Wire Drug-coated Angioplasty Balloon - Peripheral Arterial Disease
Phase 4CompletedSpectranetics Corporation492018-04-202024-01-24
Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
Dexamethasone infusion, Drug coated balloon, Plain balloon angioplasty - Peripheral Artery Disease, Vascular Disease
Phase 4CompletedUniversity of California, San Francisco332016-02-102025-07-17
Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery
Drug Eluting Balloon Angioplasty, Nitinol stenting - Peripheral Arterial Disease, Arterial Occlusive Diseases
Phase 4CompletedInstituto Dante Pazzanese de Cardiologia852014-07-012021-06-10
Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation
PEB, POBA - Critical Limb Ischemia
Phase 4CompletedLeonardo Bolognese, MD1422010-11-012013-01-29
Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions
iliac stenting - Peripheral Vascular Disease, Intermittent Claudication
Phase 4CompletedFlanders Medical Research Program3252008-12-012013-01-25
DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions
Everflex 200 - Peripheral Vascular Disease, Intermittent Claudication
Phase 4CompletedFlanders Medical Research Program1002008-03-012010-12-01
Cryoplasty CLIMB-registry
PolarCath Peripheral Dilatation System (Boston Scientific) - Critical Limb Ischemia, Peripheral Arterial Occlusive Disease
Phase 4CompletedFlanders Medical Research Program1002007-05-012010-07-05
Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft (PopUp)
6 mm Uni-graft® (B-Braun), 6 mm Gore-Tex® (WL Gore) - Intermittent Claudication, Critical Limb Ischemia
Phase 4CompletedUniversity Hospital, Gentofte, Copenhagen4001993-10-012006-03-09

Narrower conditions

Intermittent Claudication (5)  ·  Peripheral Vascular Diseases (4)  ·  Peripheral Arterial Disease (3)  ·  Atherosclerosis (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Peripheral Arterial Occlusive Disease 1 (1)  ·  Plaque, Amyloid (1)  ·  Plaque, Atherosclerotic (1)  ·  Vascular Diseases (1)

Broader conditions

Chronic Disease (8)  ·  Disease Attributes (8)  ·  Ischemia (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Arterial Occlusive Diseases (7)  ·  Arteriosclerosis (7)  ·  Cardiovascular Diseases (7)  ·  Vascular Diseases (7)  ·  Atherosclerosis (6)  ·  Peripheral Arterial Disease (5)  ·  Signs and Symptoms (5)  ·  Peripheral Vascular Diseases (4)  ·  Pathological Conditions, Anatomical (1)

Sponsors

Flanders Medical Research Program (3)  ·  Instituto Dante Pazzanese de Cardiologia (1)  ·  Leonardo Bolognese, MD (1)  ·  Spectranetics Corporation (1)  ·  University Hospital, Gentofte, Copenhagen (1)  ·  University of California, San Francisco (1)

Countries

Belgium (3)  ·  Brazil (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Marc Bosiers, MD (3)  ·  David Saloner, PhD (1)  ·  Frank Vermassen, MD (1)  ·  Gunnar Tepe, MD (1)  ·  Torben V Schroeder, Professor (1)  ·  Warren Gasper, MD (1)

Results publications

PMID 20354489, PMID 21636239, PMID 22149222, PMID 23797811, PMID 30850285, PMID 33249205, PMID 42573020

NIH funding

R01HL128816 (1)